July 23, 2026

New Data for Acquired Hypothalamic Obesity

Researchers found greater reductions in body mass index and participant-reported hunger scores with setmelanotide than with placebo, although adverse and serious adverse events were more frequent in the setmelanotide group; only one serious adverse event was considered treatment-related.

Conexiant

July 23, 2026

Exonate Taps Olav Hellebø as EXN407 Nears Phase 2b

Exonate brings in Olav Hellebø as it prepares Phase 2b trial of EXN407 for diabetic eye disease

The Ophthalmologist

July 22, 2026

Trump’s Personnel Agency Says It Will Remove Some Identifying Info as It Sweeps Up Medical Records

“Clearly, this administration has not earned our trust with Americans’ sensitive data."

Conexiant

July 20, 2026

This Week’s CGT News: First-in-Human Diabetes Cell Therapy 

First-in-human diabetes cell replacement, early iPSC-derived CAR T data in systemic sclerosis, AAV gene therapy for fragile X syndrome, and fresh funding for off-the-shelf CAR T

The Medicine Maker

July 20, 2026

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.

Conexiant

July 20, 2026

Oculomics Device Wins UK Funding

Occuity secures £1.5m grant for its eye-based diabetes screening device, SD1

The Ophthalmologist

July 16, 2026

FDA Approves First Oral PCSK9 Inhibitor

Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.

Conexiant

July 16, 2026

Oral Aleniglipron Reduced Weight at 36 Weeks

In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.

Conexiant

July 16, 2026

Do Sitting Patterns Matter?

Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.

Conexiant

July 15, 2026

Medical Oddities: Natural Doesn't Always Mean Safe

From the gym to the kitchen to romance, these studies challenge everyday assumptions.

Conexiant